METHOD OF PRODUCING N-PYRAZINOYL-L-PHENYLALANYL-L-LEUCINE BORONIC ACID OR ANHYDRIDE THEREOF Russian patent published in 2012 - IPC C07F5/02 

Abstract RU 2450011 C1

FIELD: chemistry.

SUBSTANCE: method involves reaction of trifluoroacetate (1S,2S,3R,5S)-pinanediol-(R)-1-ammonium-3-methylbutane-1-boronate with N-pyrazinoyl-L-phenylalanyl with ultrasonic activation using a suitable condensing agent in the presence of a suitable base. The formed (1S,2S,3R,5S)-pinanediol N-pyrazinoyl-L-phenylalanyl-L-leucine-boronate undergoes an exchange reaction with isobutyl boronic acid in an acidic medium to form N-pyrazinoyl-L-phenylalanyl-L-leucine boronic acid or anhydride thereof.

EFFECT: method enables to obtain an end product of higher purity and high output, and a more efficient and safer technique.

7 cl, 5 ex

Similar patents RU2450011C1

Title Year Author Number
METHOD OF OBTAINING PYRAZINOYL-(L)-PHENYLALANYL-(L)-LEUCINE BORONIC ACID OR ITS ANHYDRIDE 2008
  • Ivanov Andrej Sergeevich
  • Zhalnina Anna Aleksandrovna
  • Shishkov Sergej Viktorovich
  • Fedorov Vladimir Egorovich
  • Perminov Sergej Vladimirovich
RU2402564C2
METHOD OF INHIBITION OF RETROVIRAL PROTEASES ACTIVITY 1991
  • Karl-Khajnts Budt[De]
  • Bernd Shtovasser[De]
  • Diter Ruppert[De]
  • Kristof Majkhsner[De]
  • Arnol'D Pessene[De]
  • Jutta Khanzen[De]
  • Iokhen Knolle[De]
RU2028155C1
CONNECTIONS OF SUBSTITUTED TRIAZOLBRONIC ACID 2013
  • Linch Stiven M.
  • Najdkhart Verner
  • Plansher Zhan-Mark
  • Shults-Gash Tanya
RU2625801C2
METHOD OF SYNTHESIS OF PEPTIDE DERIVATIVES OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS 1990
  • Karl-Khajnts Budt[De]
  • Bernd Shtovasser[De]
  • Diter Ruppert[De]
  • Kristof Majkhsner[De]
  • Arnol'D Pessens[De]
  • Jutta Khanzen[De]
  • Jokhen Knolle[De]
RU2047621C1
NEW CONJUGATES BINDING COMPOUND - ACTIVE COMPOUND (ADC) AND USE THEREOF 2012
  • Lerkhen Khans-Georg
  • Linden Lars
  • El Shejkh Sherif
  • Villuda Jorg
  • Kopitts Sharlotte Kristine
  • Shumakher Ioakhim
  • Greven Zimone
  • Malert Kristof
  • Shtelte-Lyudvig Beatriks
  • Golfir Sven
  • Bajer Rudolf
  • Khajsler Iring
  • Kharrenga Aksel
  • Tiraukh Karl-Khajnts
  • Bruder Zandra
  • Petrul Khajke
  • Iorissen Khanna
  • Borkovski Zandra
RU2610336C2
ADAMANTYL DERIVATIVES USEFUL FOR TREATMENT OF JNK-MEDIATED DISORDER 2012
  • Cheun Edrian Vaj-Khin
  • Gerten Kevin Richard
  • Khejns Nensi-Ellen
  • Mertts Erik
  • Ki Lida
  • Tsyan Imin
  • Skott Natan Robert
RU2626890C2
LIGAND CONJUGATE WITH CYTOTOXIC DRUG PREPARATION, METHOD AND APPLICATION THEREOF 2016
  • Syuj Tszyanyan
  • Chzhan In
  • Tsyuj Bolej
  • Chzhan Fuyao
  • Yuj Syuchzhao
  • Lian Tszindun
  • Tszyan Gujyan
  • Chzhan Lyanshan
  • Li An
  • Van Yali
RU2708461C2
CYTOTOXIC PEPTIDES AND ANTIBODY-DRUG CONJUGATES THEREOF 2012
  • Doroski Matthew David
  • Maderna Andreas
  • O'Donnell Christopher John
  • Subramanyam Chakrapani
  • Vetelino Beth Cooper
  • Dushin Russell George
  • Strop Pavel
  • Graziani Edmund Idris
RU2586885C2
COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR 2016
  • Daj, Lue
  • Gao, Lu
RU2718917C2
DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS 2014
  • Peres Mishel
  • Rilatt Ajan
  • Lamot Mari
RU2662951C2

RU 2 450 011 C1

Authors

Shishkov Sergej Viktorovich

Zhalnina Anna Aleksandrovna

Korolev Vladimir L'Vovich

Volkov Igor' Mikhajlovich

Dates

2012-05-10Published

2010-10-26Filed